NO20016341D0 - Inhibitorer for integrinet <alfa>v<beta>6 - Google Patents

Inhibitorer for integrinet <alfa>v<beta>6

Info

Publication number
NO20016341D0
NO20016341D0 NO20016341A NO20016341A NO20016341D0 NO 20016341 D0 NO20016341 D0 NO 20016341D0 NO 20016341 A NO20016341 A NO 20016341A NO 20016341 A NO20016341 A NO 20016341A NO 20016341 D0 NO20016341 D0 NO 20016341D0
Authority
NO
Norway
Prior art keywords
alfa
integrin
inhibitors
beta
Prior art date
Application number
NO20016341A
Other languages
English (en)
Other versions
NO20016341L (no
Inventor
Alfred Jonczyk
Beate Diefenbach
Ulrich Groth
Gunther Zischinsky
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20016341D0 publication Critical patent/NO20016341D0/no
Publication of NO20016341L publication Critical patent/NO20016341L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20016341A 1999-06-26 2001-12-21 Inhibitorer for integrinet <alfa>v<beta>6 NO20016341L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19929410A DE19929410A1 (de) 1999-06-26 1999-06-26 Inhibitoren des Integrins avß6
PCT/EP2000/005404 WO2001000660A1 (de) 1999-06-26 2000-06-13 INHIBITOREN DES INTEGRINS αv$(g)b¿6?

Publications (2)

Publication Number Publication Date
NO20016341D0 true NO20016341D0 (no) 2001-12-21
NO20016341L NO20016341L (no) 2002-02-25

Family

ID=7912712

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016341A NO20016341L (no) 1999-06-26 2001-12-21 Inhibitorer for integrinet <alfa>v<beta>6

Country Status (17)

Country Link
EP (1) EP1189930A1 (no)
JP (1) JP2003503422A (no)
KR (1) KR20020015704A (no)
CN (1) CN1358195A (no)
AR (1) AR024472A1 (no)
AU (1) AU771099B2 (no)
BR (1) BR0011954A (no)
CA (1) CA2377224A1 (no)
CZ (1) CZ20014484A3 (no)
DE (1) DE19929410A1 (no)
HU (1) HUP0201729A3 (no)
MX (1) MXPA01013247A (no)
NO (1) NO20016341L (no)
PL (1) PL352374A1 (no)
SK (1) SK18722001A3 (no)
WO (1) WO2001000660A1 (no)
ZA (1) ZA200200673B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6972296B2 (en) 1999-05-07 2005-12-06 Encysive Pharmaceuticals Inc. Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
AU2004208865B2 (en) 2003-02-06 2010-06-17 Merck Patent Gmbh Peptidic sulfonamides
GB0520068D0 (en) 2005-10-03 2005-11-09 Cancer Res Technology av peptide ligand
KR20090039739A (ko) 2006-08-03 2009-04-22 아스트라제네카 아베 αＶβ６에 대해 작용하는 항체 및 그의 용도
KR102634762B1 (ko) * 2016-11-01 2024-02-06 애로우헤드 파마슈티컬스 인코포레이티드 알파-v 베타-6 인테그린 리간드 및 그의 용도
KR20200083523A (ko) 2017-11-01 2020-07-08 애로우헤드 파마슈티컬스 인코포레이티드 인테그린 리간드 및 그의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2103139A1 (en) * 1991-05-14 1992-11-15 George A. Heavner Peptide inhibitors of inflammation
US20020004482A1 (en) * 1997-08-08 2002-01-10 Xiaozhu Huang Treatment of acute lung injury and fibrosis with antagonists of avbeta6
CN1335853A (zh) * 1998-12-19 2002-02-13 默克专利股份公司 整联蛋白αvβb的抑制剂

Also Published As

Publication number Publication date
PL352374A1 (en) 2003-08-25
JP2003503422A (ja) 2003-01-28
DE19929410A1 (de) 2000-12-28
ZA200200673B (en) 2003-04-24
CA2377224A1 (en) 2001-01-04
SK18722001A3 (sk) 2002-05-09
CZ20014484A3 (cs) 2002-04-17
HUP0201729A2 (en) 2002-08-28
NO20016341L (no) 2002-02-25
CN1358195A (zh) 2002-07-10
HUP0201729A3 (en) 2005-01-28
AU6263000A (en) 2001-01-31
KR20020015704A (ko) 2002-02-28
WO2001000660A1 (de) 2001-01-04
AR024472A1 (es) 2002-10-02
BR0011954A (pt) 2002-05-07
EP1189930A1 (de) 2002-03-27
AU771099B2 (en) 2004-03-11
MXPA01013247A (es) 2002-07-02

Similar Documents

Publication Publication Date Title
NO20006268L (no) &lt;Beta&gt;karbolinforbindelser
EE04517B1 (et) Topeltkonteiner
DE69836425D1 (de) Behälter
DE60044873D1 (de) Orientierte biopolymermembrane
FI990170A0 (fi) Maksunosoitus
DE69911627D1 (de) Ausgabebehälter
ATA24499A (de) Behälter
ID28483A (id) 2-(3,5-bis-trifluorometil-fenil)-metil-n-(6-morfolin-4-il-4-0-tolil-piridin-3-il)-isobutiramida
DE69907015T2 (de) Ausgabebehälter
DE29816750U1 (de) Behälter
NO20013013D0 (no) &lt;alfa&gt;v&lt;beta&gt;6-integrininhibitorer
NO20014010D0 (no) &lt;beta&gt;-alaninderivater
FI990553A0 (fi) Mittausjärjestely
DE69928440D1 (de) Ausgabebehälter
NO20022852L (no) Beholdere
NO20016341D0 (no) Inhibitorer for integrinet &lt;alfa&gt;v&lt;beta&gt;6
FI980908A0 (fi) Rullauslaite
FI982378A0 (fi) Järjestely kohteen tutkimiseen
NO20020886D0 (no) Nye integrin- &lt;alfa&gt;v&lt;beta&gt;3-inhibitorer
NO20030925D0 (no) Gem-substituerte alfa V beta 3 integrinantagonister
DE29818035U1 (de) Behältnis
DE29805341U1 (de) Behälter
ATA36698A (de) Behälter
NO20010280L (no) &lt;Alfa&gt;-aminosyrefenylesterderivater
DE29816655U1 (de) Behälter

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application